The lactate dehydrogenase (LDH) isoenzyme spectrum enables optimally controlling T cell glycolysis and differentiation
Science Advances · 2023
DOI: 10.1126/sciadv.add9554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Xuyong Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Childhood Cancer and Blood Diseases, Hematology/Oncology and BMT, Abigail Wexner Research Institute at Nationwide Children's Hospital, The…. Hauptthemen laut MEDLINE: Isoenzymes, NAD. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Isoenzyme divergence is a prevalent mechanism governing tissue-specific and developmental stage-specific metabolism in mammals. The lactate dehydrogenase (LDH) isoenzyme spectrum reflects the tissue-specific metabolic status. We found that three tetrameric isoenzymes composed of LDHA and LDHB (LDH-3/4/5) comprise the LDH spectrum in T cells. Genetically deleting LDHA or LDHB altered the isoenzyme spectrum by removing all heterotetramers and leaving T cells with LDH-1 (the homotetramer of LDHB) or LDH-5 (the homotetramer of LDHA), respectively. Accordingly, deleting LDHA suppressed glycolysis, cell proliferation, and differentiation. Unexpectedly, deleting LDHB enhanced glycolysis but suppressed T cell differentiation, indicating that an optimal zone of glycolytic activity is required to maintain cell fitness. Mechanistically, the LDH isoenzyme spectrum imposed by LDHA and LDHB is necessary to optimize glycolysis to maintain a balanced nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide hydrogen pool. Our results suggest that the LDH isoenzyme spectrum enables “Goldilocks levels” of glycolytic and redox activity to control T cell differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Childhood Cancer and Blood Diseases, Hematology/Oncology and BMT, Abigail Wexner Research Institute at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
ORCID-Profile: Xuyong Chen, Siwen Kang, Ruoning Wang
Förderung
- NCI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Chen, X., Liu, L., Kang, S., Gnanaprakasam, J. R., & Wang, R. (2023). The lactate dehydrogenase (LDH) isoenzyme spectrum enables optimally controlling T cell glycolysis and differentiation. Science Advances. https://doi.org/10.1126/sciadv.add9554
Vancouver
Chen X, Liu L, Kang S, Gnanaprakasam JR, Wang R. The lactate dehydrogenase (LDH) isoenzyme spectrum enables optimally controlling T cell glycolysis and differentiation. Science Advances. 2023. doi:10.1126/sciadv.add9554
BibTeX
@article{Chen2023,
author = {Chen, Xuyong and Liu, Lingling and Kang, Siwen and Gnanaprakasam, Jn Rashida and Wang, Ruoning},
title = {The lactate dehydrogenase (LDH) isoenzyme spectrum enables optimally controlling T cell glycolysis and differentiation},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.add9554}
}
EUVIMED